Accessibility: Skip TopNav
Figure 1.
Individual cerebrospinal fluid (CSF) glucosylsphingosine (GluSph) log2-fold changes from baseline after 90 days of dosing with rexaceract
Format
PNG
Source
Gain Therapeutics, Inc.
Téléchargements
Original
Grand
Moyen
Petit